Afuco™ Anti-CD27 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H74) (CAT#: AFC-TAB-H74)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human antibody to Human CD27. It is an immunotherapy designed to enhance the body's natural immune response by directly activating T cells that can specifically recognize and kill cancer cells.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Normal Tissue
RNA Expression

Specifications

  • Host Species
  • Human
  • Derivation
  • human
  • Type
  • ADCC enhanced antibody
  • Specificity
  • CD27 (TNFRSF7, tumor necrosis factor receptor superfamily member 7) [Homo sapiens]
  • Species Reactivity
  • Human
  • Applications
  • ELISA, IP, FC, FuncS, Neut, IF
  • Conjugate
  • Unconjugated
  • Generic Name
  • Varlilumab
  • Related Disease
  • Solid tumors

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • CD27; CD27 molecule; TNFRSF7, tumor necrosis factor receptor superfamily, member 7; CD27 antigen; S152; Tp55; CD27L receptor; T cell activation antigen S152; T-cell activation antigen CD27; tumor necrosis factor receptor superfamily, member 7; T14;

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Varlilumab"

DrugMonitor™ Anti-Varlilumab Antibody (VS-1224-YC1278)
Varlilumab is a monoclonal antibody intended for immunotherapy of solid tumors and hematologic malignancies, used in trials for melanoma, skin ulcers, Burkitt's lymphoma, and other T-cell malignancies. The DrugMonitor™ Anti-Varlilumab Antibody (VS-1224-YC1278) is an anti-drug antibody (ADA) against Varlilumab. This drug-based antibody is raised in mice immunized with the Varlilumab. The anti-Varlilumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Varlilumab in samples.

See other products for "CD27"

Select a product category from the dropdown menu below to view related products.
Please select product type
Human Antibody Products Mouse Antibody Products Chimeric Antibody Products Humanized Antibody Products Neutralizing Antibody Products Rabbit Monoclonal Antibody Products Agonistic Antibody Products IgG Antibody Products ScFv Antibody Products Fab Antibody Products Antibody Magnetic Beads Hexamer Antibody Products Flow Cytometry (FC) related Products
CAT Product Name Application Type
TAB-H74 Human Anti-Human CD27 Recombinant Antibody (TAB-H74) ELISA, IP, FC, FuncS, Neut, IF, ICC IgG1 - kappa

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-H74. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare